| Financial Year |
March 31 2023 |
| Monetary Funds |
612,946,021.29 |
| Held-for-trading Financial Assets |
168,131,659.32 |
| Notes Receivable |
26,812,516.23 |
| Accounts Receivable |
1,344,011,183.48 |
| Advances to Suppliers |
14,213,468.76 |
| Other Receivables |
92,245,338.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
478,502,721.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
13,402,572.62 |
| Other Current Assets |
37,804,298.71 |
| Total Current Assets |
3,227,274,359.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,926,811.25 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
267,248,101.98 |
| Under-construction Projects |
34,451,177.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
131,887,201.79 |
| R&D expenses |
-- |
| Goodwill |
232,640,040.85 |
| Long-Term Deferred and Prepaid Expenses |
10,692,652.65 |
| Deferred Income Tax Assets |
51,704,937.50 |
| Other Non-Current Assets |
13,207,941.81 |
| Sub-Total of Non-Current Assets |
835,135,006.93 |
| Total Assets |
4,062,409,366.76 |
| Short-Term Loans |
484,800,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
345,875,239.81 |
| Accounts Payable |
505,910,713.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,374,153.82 |
| Taxes Payable |
33,359,466.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,160,625.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
44,480,222.62 |
| Other Current Liabilities |
52,463,631.64 |
| Sub-Total of Current Liabilities |
1,657,462,634.10 |
| Long-term Loans |
138,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
28,207,870.19 |
| Deferred Income Tax Liabilities |
3,588,827.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
245,932,520.79 |
| Total Liabilities |
1,903,395,154.89 |
| Paid-In Capital(Or Share Stock) |
434,597,230.00 |
| Capital Surplus |
702,598,801.77 |
| Surplus Reserve |
86,144,316.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
940,663,446.51 |
| Minority Stockholder's Interest |
-5,465,718.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,164,479,930.13 |
| Owner's Equity（Stockholder's Equity） |
2,159,014,211.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,062,409,366.76 |
